Biotech stocks soar as race for COVID-19 vaccine/treatment goes into overdrive
Eden Rahim, portfolio manager and options strategist at Next Edge Capital discusses the investing frenzy in biotech stocks and two companies he believes stand out among the crowd in the race for a COVID-19 vaccine.